Arrow Financial Corp Abb Vie Inc. Transaction History

Arrow Financial Corp

$1.07 Billion
Q3 2024

A detailed history of Arrow Financial Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Arrow Financial Corp holds 5,998 shares of ABBV stock, worth $989,610. This represents 0.11% of its overall portfolio holdings.

Number of Shares

5,998

Previous 6,005 0.12%

Holding current value

$989,610

Previous $1.03 Million 15.06%

% of portfolio

0.11%

Previous 0.1%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$163.84 - $199.33 $1,146 - $1,395	-7 Reduced 0.12%	5,998 $1.18 Million
Q2 2024 Jul 30, 2024	SELL	$154.79 - $180.76 $19,348 - $22,595	-125 Reduced 2.04%	6,005 $1.03 Million
Q1 2024 May 21, 2024	SELL	$159.82 - $182.1 $25,571 - $29,136	-160 Reduced 2.54%	6,130 $1.12 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $15,136 - $17,046	-110 Reduced 1.72%	6,290 $974,000
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $50,363 - $58,303	-377 Reduced 5.56%	6,400 $953,000
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $60,292 - $75,029	-455 Reduced 6.29%	6,777 $913,000
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $74,763 - $86,101	-517 Reduced 6.67%	7,232 $1.15 Million
Q4 2022 Feb 01, 2023	SELL	$138.31 - $165.87 $12,586 - $15,094	-91 Reduced 1.16%	7,749 $1.25 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $16,105 - $18,471	-120 Reduced 1.51%	7,840 $1.05 Million
Q2 2022 Jul 25, 2022	SELL	$137.62 - $174.96 $3,440 - $4,374	-25 Reduced 0.31%	7,960 $1.22 Million
Q1 2022 Apr 26, 2022	SELL	$131.98 - $163.75 $70,609 - $87,606	-535 Reduced 6.28%	7,985 $1.29 Million
Q4 2021 Jan 28, 2022	BUY	$107.43 - $135.93 $14,932 - $18,894	139 Added 1.66%	8,520 $1.15 Million
Q3 2021 Oct 21, 2021	SELL	$106.4 - $120.78 $12,980 - $14,735	-122 Reduced 1.43%	8,381 $904,000
Q2 2021 Jul 21, 2021	SELL	$105.21 - $117.21 $6,943 - $7,735	-66 Reduced 0.77%	8,503 $959,000
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $4,092 - $4,504	40 Added 0.47%	8,569 $928,000
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $2,173 - $2,934	-27 Reduced 0.32%	8,529 $914,000
Q3 2020 Nov 06, 2020	SELL	$85.91 - $100.83 $14,776 - $17,342	-172 Reduced 1.97%	8,556 $749,000
Q2 2020 Jul 27, 2020	BUY	$73.37 - $98.18 $40,133 - $53,704	547 Added 6.69%	8,728 $858,000
Q1 2020 Apr 21, 2020	BUY	$64.5 - $97.79 $9,352 - $14,179	145 Added 1.8%	8,181 $623,000
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $103,506 - $129,508	-1,435 Reduced 15.15%	8,036 $713,000
Q3 2019 Oct 28, 2019	SELL	$62.98 - $75.72 $1,574 - $1,893	-25 Reduced 0.26%	9,471 $717,000
Q4 2018 Feb 04, 2019	BUY	$77.85 - $96.01 $389 - $480	5 Added 0.05%	9,496 $875,000
Q3 2018 Oct 11, 2018	SELL	$88.91 - $98.84 $1.16 Million - $1.29 Million	-13,025 Reduced 57.85%	9,491 $898,000
Q1 2018 Apr 25, 2018	BUY	$92.01 - $123.21 $1.18 Million - $1.57 Million	12,775 Added 131.15%	22,516 $2.13 Million
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $2,507 - $2,749	-28 Reduced 0.29%	9,741 $941,000
Q3 2017 Oct 18, 2017	BUY	$69.85 - $89.22 $682,364 - $871,590	9,769	9,769 $867,000

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Financial Corp with notifications on news.

Account

Arrow Financial Corp Abb Vie Inc. Transaction History